• IT's Role Combating the Alien Invader

    Mar 28, 2013, 09:00 AM by Michael Croft
    Bio-IT World Video | At the Bio-IT World Expo last year, an all star panel took on the challenges of combating cancer and “characterizing the alien invader”. Our opportunities in cancer therapies are driven by the availability of data, the panel contented, and our challenges lie in integrating the data. On the eve of the 2013 event, we evaluate our progress.
    Full story
  • Small Data Centers Move to the Cloud

    Mar 28, 2013, 08:00 AM by Michael Croft
    ComputerWorld | Day is waning for small in-house data centers, says ComputerWorld. Large firms have been consolidating data centers for a while now, but the trend is now trickling down to smaller groups.
    Full story
  • The Newest 'Ome' for Sequencing Studies: the Squishome

    Mar 27, 2013, 08:00 AM by Michael Croft
    GigaScience | Ready for the next frontier of NGS research? Bug guts. Today in GigaScience, researchers publish a "squishomics" approach to studying biodiversity.
    Full story
  • Privacy Debates Over HeLa Cell Sequence

    Mar 26, 2013, 11:00 AM by Michael Croft
    ScienceInsider | A debate has been raging over the ethics of sequencing the HeLa cell line without the consent of Henrietta Lacks' family, and many in the community have weighed in.
    Full story
  • Nimbus Releases New Flash Storage Software

    Mar 26, 2013, 08:00 AM by Michael Croft
    SemiAccurate | Nimbus Data released a software suite--Halo 2013--for their flash storage offerings. The software is a free update for existing customers and brings an analysis system, API, and mobile monitoring suite.
    Full story
  • Systems Biology Initiative Plans Computer-Simulated Skin Model

    Mar 25, 2013, 12:00 PM by Michael Croft
    News Brief | Bio-Modeling Systems (BMSystems) of France and Persistent Systems of India are launching a joint systems biology research and development initiative that will marry non-mathematical heuristic modeling with mathematical modeling designed to increase the success rates of drug discovery and formulation development.
    Full story
  • 2012 Growth Year for HPC Market

    Mar 25, 2013, 08:00 AM by Michael Croft
    eWeek | 2012 saw record revenues in the high-performance computer market, led by IBM and HP. Supercomputers led the growth, with a 29.3% increase in revenues.
    Full story
  • History of OpenStack and NASA

    Mar 25, 2013, 08:00 AM by Michael Croft
    ComputerWorld | The OpenStack cloud platform got IBM's vote of approval earlier this month. The technology was originally tied to NASA's Nebula project a 2008.
    Full story
  • IBM's Ion Current Chips

    Mar 22, 2013, 11:00 AM by Michael Croft
    eWeek | IBM’s scientists discovered a new way to operate chips using tiny ionic currents, which are streams of charged atoms that could mimic the event-driven way in which the human brain operates.
    Full story
  • Bibliogo is RSS Reader for Life Sciences

    Mar 22, 2013, 11:00 AM by Michael Croft
    Bio-IT World Product Brief | Looking for a Google Reader replacement? Bibliogo is an RSS reader designed specifically for science, says Reprints Desk.
    Full story
  • UK Biobank and Affymetrix Sign 500,000-Sample Genotyping Agreement

    Mar 22, 2013, 09:00 AM by Michael Croft
    Bio-IT World | UK Biobank and Affymetrix have signed a contract to genotype 500,000 DNA samples donated by UK residents as part of a prospective epidemiological study of complex diseases that are of great relevance to public health using Affymetrix’ Axiom Genotyping Solution.
    Full story
  • AMCG Releases Recommendations for Dealing with Sequencing Findings

    Mar 22, 2013, 09:00 AM by Michael Croft
    Nature | The American College of Medical Genetics and Genomics yesterday released recommendations for how genome-sequencing laboratories should report incidental findings after a doctor orders a genome sequence. It defines a minimum list of about 60 genes and 30 conditions that should be reported to the doctor as part of a patient’s care, whether the patient wants to know them or not.
    Full story
  • Ra Pharmaceuticals and the Pursuit of Peptide Drugs

    Mar 22, 2013, 07:00 AM by Michael Croft
    Bio-IT World Video | Doug Treco, president & CEO of Ra Pharmaceuticals, will be presenting at CHI’s Drug Discovery Chemistry conference in San Diego in April. He gives Bio-IT World editor Kevin Davies some insight into the world of cyclomimetics.
    Full story
  • AstraZeneca Cuts More Jobs; Signs $240M+ Agreement with Moderna

    Mar 21, 2013, 09:00 AM by Michael Croft
    Bio-IT World Roundup | Lots of news for AstraZeneca this morning. The company announced plans to cut 2300 sales and administrative jobs and plans to focus on respiratory, inflammation & autoimmunity; cardiovascular & metabolic disease; and oncology. The company also announced a major agreement with Moderna Therapeutics, starting with a $240 million upfront payment for mRNA research.
    Full story
  • March Product and News Briefs

    Mar 21, 2013, 07:00 AM by Michael Croft
    Bio-IT World | News briefs for March including updates from Ingenuity, GeneInsight, University of Auckland, and the Research Resonance Network. New products from SoftGenetics, Accelrys, Cynvenio Biosystems, SGI, PerkinElmer and more.
    Full story
  • Big Data Freeway in San Diego

    Mar 20, 2013, 15:00 PM by Michael Croft
    New York Times | Larry Smarr and his team at UC  San Diego are about to open the “Big Data freeway system” for next-gen data projects including genomic sequencing. The new network--Prism--is based on an optical switch developed by Arista Networks.
    Full story
  • Following the Gleevec Blueprint

    Mar 20, 2013, 10:00 AM by Michael Croft
    Xconomy | Blueprint Medicines has reunited the team behind Gleevec—Nick Lydon, Brian Druker, and Charles Sawyers. The startup, backed with a $40 million Series A financing from Third Rock Ventures and Fidelity Biosciences in 2011, believes now is the time for more drugs like the cancer blockbuster.
    Full story
  • A Look at Gene Patents and Myriad

    Mar 20, 2013, 09:00 AM by Michael Croft
    PBS | On April 15, the Supreme Court will again hear a case against Myriad Genetics' gene patents. Though the legal debate is unlikely to end there, the decision could have implications for personalized medicine. Even the researcher who was originally responsible for the Myriad patent of BRCA2 has changed his tune.“
    Full story
  • DNA Editing Protein

    Mar 19, 2013, 09:00 AM by Michael Croft
    Forbes | They were trying to find a better way to make yogurt, but instead, they stumbled across a bacterial immune system and a protein that finds very specific DNA sequences. George Church's lab proved that the protein could make multiple, specific edits to a cell's DNA at once. From here, the possibilities are endless.
    Full story
  • Complete Genomics Acquisition Final

    Mar 19, 2013, 08:00 AM by Michael Croft
    Bio-IT World News Brief | BGI-Shenzhen has completed its acquisition of Complete Genomics through its wholly-owned subsidiary, Beta Acquisition Corporation.
    Full story